Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18765690rdf:typepubmed:Citationlld:pubmed
pubmed-article:18765690lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:18765690lifeskim:mentionsumls-concept:C0036576lld:lifeskim
pubmed-article:18765690lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:18765690lifeskim:mentionsumls-concept:C0302614lld:lifeskim
pubmed-article:18765690lifeskim:mentionsumls-concept:C1706050lld:lifeskim
pubmed-article:18765690lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:18765690lifeskim:mentionsumls-concept:C0181090lld:lifeskim
pubmed-article:18765690pubmed:issue11lld:pubmed
pubmed-article:18765690pubmed:dateCreated2008-10-24lld:pubmed
pubmed-article:18765690pubmed:abstractTextA series of 1-cyclopropyl-8-methoxy-quinazoline-2,4-diones was synthesized and evaluated for lowering the ratio of the antimicrobial MIC in gyrase resistance mutants to that in the gyr(+) (wild type) using isogenic strains of Escherichia coli. Dione features that lowered this ratio were a 3-amino group and C-7 ring structure (3-aminomethyl pyrrolidinyl < 3-aminopyrrolidinyl < diazobicyclo < 2-ethyl piperazinyl). The wild-type MIC was also lowered. With the most active derivative tested, many gyrA resistance mutant types were as susceptible as, or more susceptible than, wild-type cells. The most active 2,4-dione derivatives were also more active with two quinolone-resistant gyrB mutants than with wild-type cells. With respect to lethality, the most bacteriostatic 2,4-dione killed E. coli at a rate that was affected little by a gyrA resistance mutation, and it exhibited a rate of killing similar to its cognate fluoroquinolone at 10x the MIC. Population analysis with wild-type E. coli applied to agar showed that the mutant selection window for the most active 2,4-dione was narrower than that for the cognate fluoroquinolone or for ciprofloxacin. These data illustrate a new approach to guide early-stage antimicrobial selection. Use of antimutant activity (i.e., ratio of the antimicrobial MIC in a mutant strain to the antimicrobial MIC in a wild-type strain) as a structure-function selection criterion can be combined with traditional efforts aimed at lowering antimicrobial MICs against wild-type organisms to more effectively afford lead molecules with activity against both wild-type and mutant cells.lld:pubmed
pubmed-article:18765690pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:languageenglld:pubmed
pubmed-article:18765690pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:citationSubsetIMlld:pubmed
pubmed-article:18765690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18765690pubmed:statusMEDLINElld:pubmed
pubmed-article:18765690pubmed:monthNovlld:pubmed
pubmed-article:18765690pubmed:issn1098-6596lld:pubmed
pubmed-article:18765690pubmed:authorpubmed-author:DrlicaKarlKlld:pubmed
pubmed-article:18765690pubmed:authorpubmed-author:MalikMuhammad...lld:pubmed
pubmed-article:18765690pubmed:authorpubmed-author:RosenJonathan...lld:pubmed
pubmed-article:18765690pubmed:authorpubmed-author:KernsRobert...lld:pubmed
pubmed-article:18765690pubmed:authorpubmed-author:GermanNadezhd...lld:pubmed
pubmed-article:18765690pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18765690pubmed:volume52lld:pubmed
pubmed-article:18765690pubmed:ownerNLMlld:pubmed
pubmed-article:18765690pubmed:authorsCompleteYlld:pubmed
pubmed-article:18765690pubmed:pagination3915-21lld:pubmed
pubmed-article:18765690pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:18765690pubmed:meshHeadingpubmed-meshheading:18765690...lld:pubmed
pubmed-article:18765690pubmed:meshHeadingpubmed-meshheading:18765690...lld:pubmed
pubmed-article:18765690pubmed:meshHeadingpubmed-meshheading:18765690...lld:pubmed
pubmed-article:18765690pubmed:meshHeadingpubmed-meshheading:18765690...lld:pubmed
pubmed-article:18765690pubmed:meshHeadingpubmed-meshheading:18765690...lld:pubmed
pubmed-article:18765690pubmed:meshHeadingpubmed-meshheading:18765690...lld:pubmed
pubmed-article:18765690pubmed:meshHeadingpubmed-meshheading:18765690...lld:pubmed
pubmed-article:18765690pubmed:meshHeadingpubmed-meshheading:18765690...lld:pubmed
pubmed-article:18765690pubmed:meshHeadingpubmed-meshheading:18765690...lld:pubmed
pubmed-article:18765690pubmed:meshHeadingpubmed-meshheading:18765690...lld:pubmed
pubmed-article:18765690pubmed:year2008lld:pubmed
pubmed-article:18765690pubmed:articleTitleUse of gyrase resistance mutants to guide selection of 8-methoxy-quinazoline-2,4-diones.lld:pubmed
pubmed-article:18765690pubmed:affiliationDivision of Medicinal and Natural Products Chemistry, University of Iowa, Iowa City,Iowa 52242, USA.lld:pubmed
pubmed-article:18765690pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18765690pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:18765690lld:chembl
entrez-gene:946614entrezgene:pubmedpubmed-article:18765690lld:entrezgene
entrez-gene:948211entrezgene:pubmedpubmed-article:18765690lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18765690lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18765690lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18765690lld:pubmed